PNP Therapeutics, Inc.—an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham (UAB)—today announced that Dr. J. Claude Bennett and Mr. James F. Fuqua have joined its Board of Directors.